CP-0364

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameCP-0364

Drug Alias NameCP-0364

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionBradykinin B1 receptor antagonistsBradykinin B2 receptor antagonists

TargetsBradykinin B2 receptorBradykinin B1 receptor

Therapy Area/IndicationsInflammationRheumatic Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCortech

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCortech

Active IndicationsN/A

Inactive IndicationsInflammationRheumatic Diseases

ATC CodeN/A